Association of cyclin-dependent kinase inhibitor 2B antisense RNA 1 gene expression and rs2383207 variant with breast cancer risk and survival

CONCLUSIONS: The findings support the putative role of CDKN2B-AS1 as an epigenetic marker in BC and open a new avenue for its potential use as a therapeutic molecular target in this type of cancer.PMID:33849428 | DOI:10.1186/s11658-021-00258-9

Source: Mol Biol Cell - April 14, 2021 Category: Molecular Biology Authors: Shahad W Kattan Yahya H Hobani Sameerah Shaheen Sara H Mokhtar Mohammad H Hussein Eman A Toraih Manal S Fawzy Hussein Abdelaziz Abdalla Source Type: research